As Senior Director of Regulatory Affairs at Teva Pharmaceuticals USA, Inc., he leads regulatory strategy, submissions, and lifecycle management for complex generics spanning complex APIs, long acting injectables, respiratory therapies, combination products, and non sterile complex products
Everyones body is different, but many clients notice increased energy, improved sleep, mood stability, and weight loss within the first few weeksespecially with consistent treatment and lifestyle support
Socaa K, Doboszewska U, Szopa A, Serefko A, Wodarczyk M, Zieliska A, et al
The safest approach combines baseline inflammatory labs, documented disease stability before starting, and reassessment at 6-8 weeks